{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:57:24Z","timestamp":1793674644717,"version":"4.5.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In 2015, the International League Against Epilepsy proposed a new conceptual definition of status epilepticus (SE) with two operational dimensions (t1 and t2) to guide emergency treatment. The purpose of this study was to compare clinical characteristics and prognoses of patients at these two different time points.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a prospective observational cohort study of consecutive adults diagnosed with SE. In case of convulsive SE, t1 is 5\u2009min and t2 is 30\u2009min, whereas in case of focal SE with impaired consciousness, t1 is 10\u2009min, t2 is 60\u2009min. Data on clinical characteristics, including age, gender, history of prior seizures, neuroimaging, semiology, duration, and etiology of SE, were collected. The primary outcome was mortality, with seizure recurrence as a secondary measure, and functional status as tertiary outcome of enrolled patients at 3 months after SE onset.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We screened one hundred patients with SE, with a median age of 66\u2009years and 61% were male. Fifty-six (56.0%) patients reached t1 of SE, while 44 (44.0%) reached t2 of SE. Convulsive SE (52.0%, <jats:italic>n<\/jats:italic>\u2009=\u200952) was more common than focal SE with impaired consciousness (48.0%, <jats:italic>n<\/jats:italic>\u2009=\u200948). Status epilepticus secondary to an acute symptomatic process was the most common (50%, <jats:italic>n<\/jats:italic>\u2009=\u200950). Patients meeting t2 of SE demonstrated a remarkably increased risk of mortality (unadjusted analysis-RR 3.606, 95%CI 1.552\u20138.376, <jats:italic>p<\/jats:italic>\u2009=\u20090.003; adjusted analysis-RR 2.924, 95%CI 1.221\u20137.003, <jats:italic>p<\/jats:italic>\u2009=\u20090.016) and unfavorable functional status (unadjusted analysis-RR 1.803, 95%CI 1.280\u20132.539, <jats:italic>p<\/jats:italic>\u2009=\u20090.001; adjusted analysis-RR 1.664, 95%CI 1.184\u20132.340, <jats:italic>p<\/jats:italic>\u2009=\u20090.003) at 3 months compared to those who only reached t1 of SE. Patients reaching t2 of SE were more likely to experience seizure recurrence, however, there was no significant difference between the two cohorts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study provides strong support for the new definition of SE. Patients meeting t2 of SE tend to have a remarkably increased risk of mortality and unfavorable functional outcomes compared to those who only reached t1 of SE. Furthermore, patients were likely to experience seizure recurrence after undergoing an episode of SE. Physicians must be educated about prompt recognition and appropriate management of SE.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02868-y","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T06:03:49Z","timestamp":1663135429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Timing matters: there are significant differences in short-term outcomes between two time points of status epilepticus"],"prefix":"10.1186","volume":"22","author":[{"given":"Yiwen","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"2868_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","volume":"14","author":"JP Betjemann","year":"2015","unstructured":"Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015;14:615\u201324.","journal-title":"Lancet Neurol"},{"issue":"Suppl 8","key":"2868_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1528-1167.2007.01359.x","volume":"48","author":"F Rosenow","year":"2007","unstructured":"Rosenow F, Hamer HM, Knake S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia. 2007;48(Suppl 8):82\u20134.","journal-title":"Epilepsia."},{"key":"2868_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.yebeh.2015.04.065","volume":"49","author":"AM Kantanen","year":"2015","unstructured":"Kantanen AM, Reinikainen M, Parviainen I, Ruokonend E, Ala-Peijari M, B\u00e4cklundetal T, et al. Incidence and mortality of super-refractory status epilepticus in adults. Epilepsy Behav. 2015;49:131\u20134.","journal-title":"Epilepsy Behav"},{"key":"2868_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1468-1331.2004.00943.x","volume":"11","author":"RF Chin","year":"2004","unstructured":"Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11:800\u201310.","journal-title":"Eur J Neurol"},{"issue":"Suppl 11","key":"2868_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1528-1167.2005.00409.x","volume":"46","author":"G Logroscino","year":"2005","unstructured":"Logroscino G, Hesdorffer DC, Cascino G, Allen Hauser W, Coeytaux A, Galobardes B, et al. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia. 2005;46(Suppl 11):46\u20138.","journal-title":"Epilepsia."},{"key":"2868_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1528-1157.1994.tb02908.x","volume":"35","author":"AR Towne","year":"1994","unstructured":"Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27\u201334.","journal-title":"Epilepsia."},{"key":"2868_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrneurol.2013.154","volume":"9","author":"R Sutter","year":"2013","unstructured":"Sutter R, Kaplan PW, R\u00fcegg S. Outcome predictors for status epilepticus\u2014what really counts. Nat Rev Neurol. 2013;9:525\u201334.","journal-title":"Nat Rev Neurol"},{"key":"2868_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1528-1157.1999.tb02070.x","volume":"40","author":"RJ DeLorenzo","year":"1999","unstructured":"DeLorenzo RJ, Garnett LK, Towne AR, Waterhouse EJ, Boggs JG, Morton L, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40:164\u20139.","journal-title":"Epilepsia."},{"key":"2868_CR9","doi-asserted-by":"crossref","unstructured":"Bone RC. Recommendations of the Epilepsy Foundation of America\u2019s Working Group on Status Epilepticus. Treatment of convulsive status epilepticus. JAMA. 1993;270:854\u201349.","DOI":"10.1001\/jama.1993.03510070076040"},{"key":"2868_CR10","doi-asserted-by":"crossref","unstructured":"Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia. 1993;34:592\u20136.","DOI":"10.1111\/j.1528-1157.1993.tb00433.x"},{"key":"2868_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","volume":"40","author":"DH Lowenstein","year":"1999","unstructured":"Lowenstein DH, Bleck T, MacDonald RL. It\u2019s time to revise the definition of status epilepticus. Epilepsia. 1999;40:120\u20132.","journal-title":"Epilepsia."},{"key":"2868_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ana.1018","volume":"49","author":"S Shinnar","year":"2001","unstructured":"Shinnar S, Berg AT, Moshe SL, Shinnar R. How long do new-onset seizures in children last. Ann Neurol. 2001;49:659\u201364.","journal-title":"Ann Neurol"},{"key":"2868_CR13","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/j.1528-1167.2006.00622.x","volume":"47","author":"S Jenssen","year":"2006","unstructured":"Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia. 2006;47:1499\u2013503.","journal-title":"Epilepsia."},{"key":"2868_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yebeh.2015.03.023","volume":"49","author":"J Dobesberger","year":"2015","unstructured":"Dobesberger J, Ristic AJ, Walser G, Kuchukhidze G, Unterberger I, H\u00f6fler J, et al. Duration of focal complex, secondarily generalized tonic-clonic, and primarily generalized tonic-clonic seizures: a video-EEG analysis. Epilepsy Behav. 2015;49:111\u20137.","journal-title":"Epilepsy Behav"},{"key":"2868_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","volume":"50","author":"DM Jones","year":"2002","unstructured":"Jones DM, Esmaeil N, Maren S, Macdonald RL. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res. 2002;50:301\u201312.","journal-title":"Epilepsy Res"},{"key":"2868_CR16","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus\u2013Report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515\u201323.","journal-title":"Epilepsia."},{"key":"2868_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3\u201323.","journal-title":"Neurocrit Care"},{"key":"2868_CR18","first-page":"2104","volume":"12","author":"J Kapur","year":"2019","unstructured":"Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;12:2104\u201313.","journal-title":"N Engl J Med"},{"key":"2868_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12028-014-0080-y","volume":"22","author":"M Leitinger","year":"2015","unstructured":"Leitinger M, Holler Y, Kalss G, Rohracher A, Novak HF, Hofler J, et al. Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care. 2015;22:273\u201382.","journal-title":"Neurocrit Care"},{"key":"2868_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","volume":"77","author":"AO Rossetti","year":"2006","unstructured":"Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: role of etiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry. 2006;77:611\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2868_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13054-016-1221-9","volume":"20","author":"G Qiong","year":"2016","unstructured":"Qiong G, Tang-peng OY, Xiao-long S, Feng Y, Chen W, Tao K, et al. Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score. Crit Care. 2016;20:46.","journal-title":"Crit Care"},{"key":"2868_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","volume":"38","author":"LJ Hirsch","year":"2021","unstructured":"Hirsch LJ, Fong MWK, Leitinger M, LaRoche SM, Beniczky S, Abend NS, et al. American clinical neurophysiology society\u2019s standardized critical care EEG terminology: 2021 Version. J Clin Neurophysiol. 2021;38:1\u201329.","journal-title":"J Clin Neurophysiol"},{"issue":"Suppl 6","key":"2868_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/epi.12270","volume":"54","author":"S Beniczky","year":"2013","unstructured":"Beniczky S, Hirsch LJ, Kaplan PW, Pressler R, Bauer G, Aurlien H, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 2013;54(Suppl 6):28\u20139.","journal-title":"Epilepsia."},{"key":"2868_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","volume":"49","author":"M Leitinger","year":"2015","unstructured":"Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E, et al. Salzburg consensus criteria for non-convulsive status epilepticus\u2013approach to clinical application. Epilepsy Behav. 2015;49:158\u201363.","journal-title":"Epilepsy Behav"},{"key":"2868_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604\u20137.","journal-title":"Stroke."},{"issue":"7","key":"2868_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"JY Zou","year":"2004","unstructured":"Zou JY. A Modified Poisson Regression Approach to Prospective Studies with Binary Data. Am J Epidemiol. 2004;159(7):702\u20136.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2868_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1528-1167.2009.02285.x","volume":"51","author":"E Beghi","year":"2010","unstructured":"Beghi E, Carpi A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, et al. Recommendations for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671\u20135.","journal-title":"Epilepsia."},{"key":"2868_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.eplepsyres.2017.07.006","volume":"136","author":"L Rui-Juan","year":"2017","unstructured":"Rui-Juan L, Qun W, Tao C, Fei Z, Xiao-Qiu S. Status epilepticus related etiology, incidence and mortality: a meta-analysis. Epilepsy Res. 2017;136:12\u20137.","journal-title":"Epilepsy Res"},{"key":"2868_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1212\/WNL.50.3.735","volume":"50","author":"DC Hesdorffer","year":"1988","unstructured":"Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965\u20131984. Neurology. 1988;50:735\u201341.","journal-title":"Neurology."},{"key":"2868_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/WNL.55.5.693","volume":"55","author":"A Coeytaux","year":"2000","unstructured":"Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology. 2000;55:693\u20137.","journal-title":"Neurology."},{"key":"2868_CR31","first-page":"1683","volume":"24","author":"SE Nelson","year":"2018","unstructured":"Nelson SE, Varelas PN. Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Neurocrit Care. 2018;24:1683\u2013707.","journal-title":"Neurocrit Care"},{"key":"2868_CR32","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1212\/WNL.58.7.1070","volume":"58","author":"YW Wu","year":"2002","unstructured":"Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology. 2002;58:1070\u2013706.","journal-title":"Neurology."},{"key":"2868_CR33","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2017.4382","volume":"75","author":"M Ga\u00ednza-Lein","year":"2018","unstructured":"Ga\u00ednza-Lein M, Fern\u00e1ndez IS, Jackson M, Abend NS, Arya R, Brenton JN, et al. Association of Time to Treatment with Outcomes for Pediatric Patients with Status Epilepticus. JAMA Neurol. 2018;75:410\u20138.","journal-title":"JAMA Neurol"},{"key":"2868_CR34","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1212\/WNL.0000000000001673","volume":"84","author":"IS Fern\u00e1ndez","year":"2015","unstructured":"Fern\u00e1ndez IS, Abend NS, Agadi S, An S, Arya R, Brenton JN, et al. Pediatric Status Epilepticus Research Group (pSERG). Time from convulsive status epilepticus onset to anticonvulsant administration in children. Neurology. 2015;84:2304\u201311.","journal-title":"Neurology."},{"key":"2868_CR35","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ana.410440609","volume":"44","author":"DC Hesdorffer","year":"1998","unstructured":"Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol. 1998;44:908\u201312.","journal-title":"Ann Neurol"},{"key":"2868_CR36","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/j.1528-1167.2009.02409.x","volume":"51","author":"H Leung","year":"2010","unstructured":"Leung H, Man CBL, Hui ACF, Kwan P, Wong KS. Prognosticating acute symptomatic seizures using two different seizure outcomes. Epilepsia. 2010;51:1570\u20139.","journal-title":"Epilepsia."},{"key":"2868_CR37","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1111\/epi.12852","volume":"55","author":"V Alvarez","year":"2014","unstructured":"Alvarez V, Westover MB, Drislane FW, Dworetzky BA, Curley D, Lee JW, et al. Evaluation of a clinical tool for early etiology identification in status epilepticus. Epilepsia. 2014;55:2059\u201368.","journal-title":"Epilepsia."},{"key":"2868_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.eplepsyres.2013.08.001","volume":"107","author":"K Rantsch","year":"2013","unstructured":"Rantsch K, Walter U, Wittstock M, Benecke R, Rosche J. Treatment and course of different subtypes of status epilepticus. Epilepsy Res. 2013;107:156\u201362.","journal-title":"Epilepsy Res"},{"key":"2868_CR39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jns.2016.10.004","volume":"370","author":"JY Cheng","year":"2016","unstructured":"Cheng JY. Latency to treatment of status epilepticus is associated with mortality and functional status. J Neurol Sci. 2016;370:290\u20135.","journal-title":"J Neurol Sci"},{"key":"2868_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00415-012-6644-x","volume":"260","author":"AO Rossetti","year":"2013","unstructured":"Rossetti AO, Alvarez V, Januel JM, Burnand B. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol. 2013;260:421\u20138.","journal-title":"J Neurol"},{"key":"2868_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ana.24986","volume":"82","author":"CE Hill","year":"2017","unstructured":"Hill CE, Parikh AO, Ellis C, Nyers JS, Litt B. Timing Is everything: where status epilepticus treatment fails. Ann Neurol. 2017;82:155\u201365.","journal-title":"Ann Neurol"},{"key":"2868_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2018.05.021","volume":"68","author":"M Ga\u00ednza-Leina","year":"2018","unstructured":"Ga\u00ednza-Leina M, Fern\u00e1ndeza IS, Ulate-Campos A, Loddenkemper T, Ostendorf AP. Timing in the treatment of status epilepticus: from basics to the clinic. Seizure. 2018;68:22\u201330.","journal-title":"Seizure."},{"key":"2868_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16:48\u201361.","journal-title":"Epilepsy Curr"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02868-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02868-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02868-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T07:07:52Z","timestamp":1663139272000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02868-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2868"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02868-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Zhongshan Hospital and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. Because this study focused on the acute phase of critically ill patients, written informed consent was obtained from participants\u2019 immediate family members. Subject rights and confidentiality were protected by using anonymous clinical data in all analyses. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines\u3002.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}